ArticleMolecules (Basel, Switzerland)2026
A Multitask Active Learning Framework with Probabilistic Modeling for Multi-Species Acute Toxicity Prediction.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Predicting acute toxicity across species is essential for early-stage drug safety evaluation. While recent efforts have primarily focused on improving predictive accuracy, they often fail to address two critical issues: the substantial divergence in toxicity mechanisms among different species, and the inherent noise present in experimental data. To bridge this gap, we introduce a Probabilistic Multitask Active Learning (PMAL) framework for multi-species acute toxicity prediction. Our framework integrates two key modules: a Probabilistic Multitask Learning (PML) component which jointly models the predictive distributions of multiple toxicity endpoints from a probabilistic viewpoint, and an Uncertainty-based Active Learning (UAL) component which strategically selects the most informative compounds for experimental annotation based on predictive uncertainty. Empirical evaluations demonstrate that PMAL surpasses state-of-the-art methods and is capable of providing well-calibrated uncertainty estimates for small molecules across diverse toxicity endpoints. Beyond advancing multi-species toxicity prediction, the core design principles of PMAL offer a generalizable paradigm for learning in noisy multi-task environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.